Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Skip to main content

Parallel detection of estrogenic and androgenic activity

One research topic at the department of Biochemistry and Ecotoxicology of the German BfG (Federal Institute of Hydrology) is the development and improvement of effect-based methods for the rapid and cost-effective screening of environmental samples. Researchers of the Life Sciences Institute at the Hebrew University of Jerusalem focus on the genetic engineering of whole-cell biosensors, the development of novel bioreporters and the directed evolution process for the improvement of sensor performance. The collaboration between these two working groups is part of the German-Israeli cooperation in the water technology research project „Tracking Effects of Environmental organic micro-pollutants in the Subsurface“ (TREES), aiming at broadening the application of bioassays performed in combination with HPTLC.

Introduction

Endocrine disrupting compounds that enter the aquatic environment, e.g., via wastewater treatment plant (WWTP) effluents, can affect the natural hormonal activity of freshwater organisms and thus pose a potential ecological threat even at low concentrations [1]. Prominent endocrine disrupting compounds bind to estrogen (ER) and androgen (AR) receptors, and thus trigger estrogenic and androgenic activity. These modes of action are detected with genetically engineered yeast cells, emitting a detectable fluorescence signal upon exposure to compounds exerting hormonal activity.

Following studies performed with Arxula adeninivorans yeast strains [2], the authors show here the parallel biological detection of estrogenicity and androgenicity in HPTLC-separated sample components using newly generated biosensors based on Saccharomyces cerevisiae. These biosensors express human estrogen and androgen receptors, co-transfected with respective reporting elements that produce either the red fluorescent protein mRuby2 in response to an estrogenic stimulus (ER-Ruby) or the blue fluorescent protein mTagBFP2 in response to an androgenic stimulus (AR-BFP).

The advantage of using HPTLC lies in its biocompatibility, which allows the combination of sample fractionation with biological effect detection directly on HPTLC plates. Several samples can be screened for estrogenicity and androgenicity on parallel tracks simultaneously, thus reducing time and effort. Its matrix robustness allows the assessment of samples with complex and heavy matrices such as WWTP influents.

Standard solutions

Stock solutions of testosterone (0.5 mg/mL) and dihydrotestosterone (DHT, 5 mg/mL) are prepared in ethanol as androgenic reference compounds. Estrone (E1), 17ß-estradiol (E2) and estriol (E3) in ethanolic stock solutions of 5 mg/mL serve as estrogenic reference compounds. An androgenic and an estrogenic mixture was prepared and diluted depending on range-finding tests.

Sample preparation

Influent and effluent grab samples of two different municipal WWTP are enriched 200x and 500x by solid-phase extraction, respectively.

Chromatogram layer

HPTLC plates silica gel 60 F254 (Merck), 20 x 10 cm, are used. Plates are pre-developed with 100% methanol to 95 mm, dried in an oven at 120 °C, and then stored in a desiccator at room temperature.

Sample application

The application of samples and standard solutions as bands is performed with the Automatic TLC Sampler (ATS 4): up to 11 tracks, band length 5.0 mm, distance from left edge 20.0 mm, track distance 16.0 mm, distance from lower edge 8.0 mm, application volume 10.0 to 20.0 μL for sample solutions and 5.0 to 10.0 μL for standard solutions.

Chromatography

HPTLC plates are developed in the Automated Multiple Development System (AMD 2). A focusing step is performed with 100% methanol to a migration distance of 20 mm, followed by drying for 2 min. In a second step, the development to a migration distance of 90 mm is conducted with ethyl acetate – n-hexane 1:1 (v/v) followed by drying for 5 min.

Yeast biosensors

For the planar bioassay, a yeast co-culture is prepared by mixing AR-BFP and ER-Ruby yeast cell cultures, previously adjusted separately to 1000 ± 50 formazine attenuation units. Then, 3.0 mL of this yeast co-culture are sprayed onto HPTLC plates using the Derivatizer (nozzle: yellow, level: 5). Plates are incubated at 30 °C for 18 h.

Documentation

Images are captured in UV 366 nm and white light with the TLC Visualizer.

Densitometry

Fluorescence measurement is performed with TLC Scanner 4 and visionCATS (slit dimension 10.0 x 0.6 mm and scanning speed 20 mm/s). The slit-dimensions reported in Schoenborn et al. (2017) [3] were used for these experiments; however, a further optimization of the slit dimensions under consideration of the signal broadening might improve the results. For detection of estrogenicity (ER-Ruby), excitation wavelength λex = 525 nm and a K540 nm filter is applied. The detection of androgenicity (AR-BFP) is performed using an excitation wavelength λex = 396 nm and a K400 nm filter.

Results and discussion

The aim of the presented study was to generate yeast-based fluorescent biosensors for the parallel detection of estrogenicity and androgenicity. In contrast to yeast-based biosensors using the expression of LacZ as reporting element, which requires the disruption of the cell wall and the addition of an external substrate [3], the presented biosensors allow a fast signal detection in living cells.

The general functionality of the individual yeast biosensors was assessed in 96-well plates and in combination with HPTLC, using either individual reference compounds or their mixtures [4].

Then, the combination of the two yeast biosensors as co-culture was investigated, using three dilutions of an estrogen mix of E1, E2 and E3 and an androgen mix of testosterone and DHT. The estrogen mix was applied on tracks 1–3, the androgen mix on tracks 4–6, and both mixtures were applied on tracks 7–9. Ethanol served as control on track 10. A distinction of the different hormonal activities in the same test can be made by changing the excitation wavelength for scanning. The repeatability was determined by calculating the standard error of minimum three replicates performed on different days, using separate aliquots of the cell suspension.

Dose-effect relationships of the estrogenic and androgenic components in the mixtures were detected. The ER-Ruby biosensor detects only estrogenic compounds (red), even in the presence of androgenic compounds, highlighting the specificity of this biosensor. A slight decrease in the signal intensity at λex = 525 nm was detected, when estrogenic and androgenic model compounds were applied in a mixture. This suggests a weaker expression of the Ruby protein under these conditions.

Regarding the AR-BFP strain, the signal intensity of androgenic compounds (blue) remains unchanged in the presence of estrogenic compounds. However, some interference at the hRF values specific for E1 and E3 is observed in case of high concentrations of the reference compounds. These signals were also detectable when only the ER Ruby biosensor was applied [4]. Possibly, high concentrations of the Ruby protein lead to detectable excitation of Ruby at λex = 396 nm. On the other hand, the used lamps have a low output at 396 nm, which is as well very close to the cut-off filter at 400 nm. In any case, the optical system has to be refined by optimized filters used for the scanning, which might help avoiding this artefact in the future.

An example of the yeast-based biosensor application for a simultaneous screening for androgenicity and estrogenicity using influent samples from a municipal WWTP is shown below. Matrix components are observable below the focusing line and are thus well separated from active compounds. Both influent samples showed estrogenicity and androgenicity. Due to the similar structures and physico-chemical properties of estrogens and androgens, a separation of the two compound classes by HPTLC is challenging [2]. However, the multi-parallel effect assessment in combination with HPTLC allows the detection of the different effects even if the active compounds are not fully separated. In the presented WWTP influents, two strong estrogenic and androgenic signals overlap at hRF values of 75 and 61, indicating the possible presence of E1 (hRF = 76), E2 (hRF = 60) and DHT (hRF = 61). For the androgenic band at hRF = 75, no candidate compound can be assigned. At some positions, signals from the ER-Ruby strain are visible between the tracks. Due to the leakiness of promoters, each reporter strain produces a background signal, which might be detectable especially at positions where cell densities are higher due to an inhomogeneous application of cells. However, an automated spraying device (Derivatizer) was used resulting in an even application of the cells. A further possibility is a signal broadening that can happen when silicaplates are used.

In conclusion, the presented study showed a proof of principle of the parallel detection of estrogenic and androgenic effects using a fluorescent yeast-based biosensor co-culture.


  • Applicability of a yeast co-culture for parallel detection of estrogenicity and androgenicity in model compound mixtures by fluorescence scanning at λex = 396 nm (blue) and λex = 525 nm (red).

    01

    Applicability of a yeast co-culture for parallel detection of estrogenicity and androgenicity in model compound mixtures by fluorescence scanning at λex = 396 nm (blue) and λex = 525 nm (red). Estrogen mix consisting of E1 (0.01 ng, 0.05 ng and 0.1 ng), E2 (0.005 ng, 0.01 ng and 0.02 ng), and E3 (0.5 ng, 1 ng and 2 ng) was applied on tracks 1–3 and 7–9. Androgen mix consisting of testosterone (T; 0.5 ng, 1.0 ng and 5.0 ng) and DHT (0.5 ng, 1.0 ng and 5.0 ng) was applied on tracks 4–6 and 7–9. Reproduced with modifications from [4] (https://creativecommons.org/licenses/by/4.0/legalcode ).

  • Parallel detection of estrogenicity and androgenicity in wastewater treatment plant influents using a yeast-based biosensor co-culture of ER-Ruby (red, λex = 525 nm) and AR-BFP (blue, λex = 396 nm).

    02

    Parallel detection of estrogenicity and androgenicity in wastewater treatment plant influents using a yeast-based biosensor co-culture of ER-Ruby (red, λex = 525 nm) and AR-BFP (blue, λex = 396 nm). Estrogen mix: E1 (a: 0.1, b: 0.2 and c: 0.4 ng), E2 (0, 20 and 40 pg) and E3 (1, 2 and 4 ng); androgen mix: DHT (a: 10, b: 25 and c: 50 ng) and testosterone (T; a: 10, b: 25 and c: 50 ng). Top: plate image displaying the fluorescent signal enhanced using the enhancement tool of the visionCATS software. Reproduced with modifications from [4] (https://creativecommons.org/licenses/by/4.0/legalcode).

Literature

[1] A.P.A. Da Silva et al. Aquat. Sci. Technol (2018) 6: 35-51.
[2] A. Chamas et al. Sci. Total Environ. (2017) 605–606:507–513.
[3] A. Schoenborn et al. J Chromatogr A (2017) 1530:185–91.
[4] L. Moscovici et al. Biosensors (2020) 10(11): 169.

Further information on request from the authors.

Contact:

Carolin Riegraf, Federal Institute of Hydrology, Am Mainzer Tor 1, 56068 Koblenz, Germany. Present address: Swiss Centre for Applied Ecotoxicology, Überlandstrasse 133, 8600 Dübendorf, Switzerland, carolin.riegraf[at]oekotoxzentrum.ch

The authors acknowledge Marina Ohlig and Ramona Pfänder also involved in the TREESproject funded by the Federal Ministry of Education and Research (BMBF) Germany (Grant No. 02WIL1387), and the Ministry of Science, Technology and Space (MOST) Israel (Grant No. WT1402/2560).

mentioned products

The following products were used in this case study

Continue reading

Use of quantified Reference Extracts for herbal materials

Dr. Daniel Jean is the founder and director of ISV (Institut des Substances Végétales, France), which produces the quantified Reference Extracts (qRE) used in this study. Dr. Ophélie Fadel is the head of the application laboratory of Chromacim (France). Dr. Debora Frommenwiler is scientist at CAMAG (Switzerland), and Dr. René De Vaumas is the CEO of Extrasynthese (France), the distributor of qRE.

Introduction

Quality control of herbal drugs, extracts and products is a challenging task because it requires proper identification and determination of content of active compounds or markers. Because monographs of the pharmacopoeias typically require independent methods for these tasks, the cost of analysis may be quite high. Reference materials are a major contribution to the cost. Quantified Reference Extracts (qRE) may be considered as suitable reference material in this context, reducing the need for stocking several separate chemical reference substances.

The goal of this work was to elaborate examples for using qRE for identification of plant materials and quantification of markers.

Standard solutions

For ginkgo, 0.2 mg/mL each of rutin and quercetin are prepared in methanol. The qRE Ginkgo biloba leaves is prepared at 30 mg/mL in methanol. For olive leaf, oleuropein is prepared at 1.0 mg/mL in methanol. For rosemary, rosmarinic acid is prepared at 0.25 mg/mL in ethanol, and the qRE Rosmarinus officinalis leaves at 1.0 mg/mL in 50% ethanol.

Sample preparation

1.0 g of powdered ginkgo leaf is mixed with 10 mL of methanol and refluxed in a water bath for 10 minutes. The mixture is centrifuged and the supernatant is used as test solution. The rosemary dried extract is prepared at 1.0 mg/mL in methanol. The qRE Olea europaea leaves (used as a sample) is prepared at 1.0 mg/mL.

Chromatogram layer

HPTLC plates silica gel 60 F254 (Merck), 20 x 10 cm are used.

Sample application

Automatic TLC Sampler (ATS 4), application as bands, 15 tracks, band length 8.0 mm, distance from left edge 20.0 mm, distance from lower edge 8.0 mm. For the ginkgo project, application volume of 3.0 μL for sample solutions and for standard solutions. For olive leave different volumes of the oleuropein standard and 10.0 μL of the qRE were applied. For rosemary, the solution of the qRE was applied with different application volumes, and the rosemary dried extract was applied with 10.0 μL.

Chromatography

In the ADC 2 with 20 min chamber saturation (with saturation pad) and after activation of the plate at 33% relative humidity for 10 min using a saturated solution of magnesium chloride. The developing distance is 70.0 mm (from the lower edge). Plates are dried for 5 min. Ethyl acetate – formic acid – acetic acid – water 100:11:11:26 (v/v) is used as developing solvent.

Post chromatographic derivatization

For rosemary and ginkgo, the plates are heated using the TLC Plate Heater (100 °C, 3 min), then derivatized with NP reagent (1.0 g 2-aminoethyl diphenylborinate in 100 mL methanol) using the Derivatizer (3.0 mL, nozzle: green, level: 4). For olive leaf, the plate is derivatized with anisaldehyde (AS) reagent (0.5 mL of p-anisaldehyde dissolved in

Documentation

TLC Visualizer in UV 254 nm, UV 366 nm, and white light prior to derivatization, and UV 366 nm, and white light after derivatization.

Densitometry

TLC Scanner 4 and visionCATS, absorbance measurement at 254 nm and 238 nm, slit dimension 5.00 mm x 0.20 mm, scanning speed 50 mm/s, for oleuropein and in fluorescence mode at 366>/400 nm for rosmarinic acid.

Results and discussion

The first part of the project demonstrates the suitability of the ginkgo quantified Reference Extract as a standard for identification. The fingerprint of the qRE was compared to a reference sample of powdered ginkgo leaf extracted with methanol (track 3) or with 50% ethanol (track 4), respectively, and a market sample of ginkgo leaf dried extract (track 5). The fingerprint of the qRE resembles those of the corresponding herbal drugs and dried extract.

The second part of the study concerned the verification of the assigned content of oleuropein and rosmarinic acid in their respective qRE by HPTLC. Assigned contents, given in the qRE’s certificate of analysis, were initially determined by HPLC. Chemical reference substances were used for quantification, and different detection modes were compared. Comparable contents were found for both markers.

The third part of the study used one qRE and its assigned content of rosmarinic acid as reference for the quantification of rosmarinic acid in a rosemary dried extract. A solution of the qRE was applied with different application volumes to give a linear calibration curve. The content of rosmarinic acid in the sample was determined at 6.3%.


  • Fingerprints of ginkgo leaf

    01

    Fingerprints of ginkgo leaf in UV 254 nm (A) and UV 366 nm (B) prior to derivatization, and in UV 366 nm after derivatization (C). Track 1: rutin, quercetin (with increasing RF); 2: qRE extract; 3–4: powdered leaf; 5: dry extract.

  • Quantification of oleuropein and rosmarinic acid in the qRE extracts

    02

    Quantification of oleuropein and rosmarinic acid in the qRE extracts

  • Fingerprints of the qRE calibration curve and the sample. Image in UV 366 nm

    03

    Fingerprints of the qRE calibration curve and the sample. Image in UV 366 nm

  • Fingerprints of the qRE calibration curve and the sample. Calibration curve

    04

    Fingerprints of the qRE calibration curve and the sample. Calibration curve

Conclusion

These examples show that qRE work well for the identification of plant materials and quantification of markers by HPTLC. For use in quality control, methods may need to be adapted from pharmacopoeia monographs.

Further information on request from the authors.

Contact:

Dr.Ophélie Fadel, of[at]chromacim.com
Dr. Debora Frommenwiler, debora.frommenwiler[at]camag.com
Dr. Daniel Jean, daniel.jean[at]insuveg.com
Dr. René De Vaumas, rdv[at]extrasynthese.com

mentioned products

The following products were used in this case study

Continue reading

Fully Automated Determination of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Dried Blood Spots

Abstract

Purpose

Direct alcohol markers are widely applied during abstinence monitoring, driving aptitude assessments and workplace drug testing. The most promising direct alcohol marker was found to be phosphatidylethanol (PEth). Compared to other markers it shows a long window of detection due to accumulation in blood. To facilitate and accelerate the determination of PEth in DBS, we developed a fully automated analysis approach.

Methods

The validated and novel online-SPE-LC-MS/MS method with automated sample preparation using a CAMAG DBS-MS 500 system reduces manual sample preparation to an absolute minimum, only requiring calibration and quality control DBS.

Results

During the validation process, the method showed a high extraction efficiency (>88%), linearity (correlation coefficient >0.9953), accuracy and precision (within ±15%) for the determination of PEth 16:0/18:1 and PEth 16:0/18:2. Within a run time of about 7 min, the two monitored analogs could be baseline separated. A method comparison in liquid whole blood of 28 authentic samples from alcohol use disorder patients showed a mean deviation of less than 2% and a correlation coefficient of >0.9759. The comparison with manual DBS extraction showed a mean deviation of less than 8% and a correlation coefficient of >0.9666.

Conclusions

The automated analysis of PEth in DBS can provide a fast and accurate solution for abstinence monitoring. In contrast to the manual extraction of PEth in DBS, no laborious sample preparation is required with this automated approach. Furthermore, the application of the internal standard by a spray module can compensate for extraction bias and matrix effects. https://academic.oup.com/jat/article-abstract/43/6/489/5486352?redirectedFrom=fulltext
camag publication

Fully Automated Determination of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Dried Blood Spots

Abstract

Purpose

Direct alcohol markers are widely applied during abstinence monitoring, driving aptitude assessments and workplace drug testing. The most promising direct alcohol marker was found to be phosphatidylethanol (PEth). Compared to other markers it shows a long window of detection due to accumulation in blood. To facilitate and accelerate the determination of PEth in DBS, we developed a fully automated analysis approach.

Methods

The validated and novel online-SPE-LC-MS/MS method with automated sample preparation using a CAMAG DBS-MS 500 system reduces manual sample preparation to an absolute minimum, only requiring calibration and quality control DBS.

Results

During the validation process, the method showed a high extraction efficiency (>88%), linearity (correlation coefficient >0.9953), accuracy and precision (within ±15%) for the determination of PEth 16:0/18:1 and PEth 16:0/18:2. Within a run time of about 7 min, the two monitored analogs could be baseline separated. A method comparison in liquid whole blood of 28 authentic samples from alcohol use disorder patients showed a mean deviation of less than 2% and a correlation coefficient of >0.9759. The comparison with manual DBS extraction showed a mean deviation of less than 8% and a correlation coefficient of >0.9666.

Conclusions

The automated analysis of PEth in DBS can provide a fast and accurate solution for abstinence monitoring. In contrast to the manual extraction of PEth in DBS, no laborious sample preparation is required with this automated approach. Furthermore, the application of the internal standard by a spray module can compensate for extraction bias and matrix effects.

https://academic.oup.com/jat/article-abstract/43/6/489/5486352?redirectedFrom=fulltext

 

Using Dried Blood Spots to facilitate Therapeutic Drug Monitoring of Antiretroviral Drugs in Resource-poor Regions

Abstract

Objectives

We evaluated whether dried blood spots (DBS) are suitable to monitor combined ART when samples are collected in rural Tanzania and transported over a long distance to a specialized bioanalytical laboratory.

Methods

Plasma and DBS samples were collected in Tanzania from study patients treated with nevirapine, efavirenz or lopinavir. In addition, plasma, whole blood and DBS samples were obtained from a cohort of HIV patients at the site of the bioanalytical laboratory in Switzerland. DBS samples were analysed using a fully automated LC-MS/MS method.

Results

Comparison of DBS versus plasma concentrations of samples obtained from the bridging study in Switzerland indicated an acceptable bias only for nevirapine (18.4%), whereas for efavirenz and lopinavir a pronounced difference of −47.4% and −48.1% was found, respectively. Adjusting the DBS concentrations by the haematocrit and the fraction of drug bound to plasma proteins removed this bias [efavirenz +9.4% (−6.9% to +25.7%), lopinavir +2.2% (−20.0% to +24.2%)]. Storage and transportation of samples from Tanzania to Switzerland did not affect the good agreement between plasma and DBS for nevirapine [–2.9% (−34.7% to +29.0%)] and efavirenz [–9.6% (−42.9% to +23.8%)]. For lopinavir, however, adjusted DBS concentrations remained considerably below [–32.8% (−70.4% to +4.8%)] corresponding plasma concentrations due to decay of lopinavir in DBS obtained under field conditions.

Conclusions

Our field study shows that the DBS technique is a suitable tool for therapeutic drug monitoring in resource-poor regions; however, sample stability remains an issue for certain analytes and therefore needs special consideration.

https://academic.oup.com/jac/article-abstract/73/10/2729/5057984?redirectedFrom=fulltext

Fully Automated Drug Screening of Dried Blood Spots using Online LC-MS/MS Analysis

Abstract

A new and fully automated workflow for the cost effective drug screening of large populations based on the dried blood spot (DBS) technology was introduced in this study. DBS were prepared by spotting 15 μL of whole blood, previously spiked with alprazolam, amphetamine, cocaine, codeine, diazepam, fentanyl, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphet-amine (MDMA), methadone, methamphetamine, morphine and oxycodone onto filter paper cards. The dried spots were scanned, spiked with deuterated standards and directly extracted. The extract was transferred online to an analytical LC column and then to the electrospray ionization tandem mass spectrometry system. All drugs were quantified at their cut-off level and good precision and correlation within the calibration range was obtained. The method was finally applied to DBS samples from two patients with back pain and codeine and oxycodone could be identified and quantified accurately below the level of misuse of 89.6 ng/mL and 39.6 ng/mL respectively.

To read the complete publication, click here.

Dried blood spots for anti-doping: Why just going volumetric may not be sufficient

Abstract

In addition to the naturally existing HCT fluctuation in a standard population, these fluctuations in an athlete population are more pronounced. Therefore, additional efforts for anti-doping testing may be required to ensure reliable and quantitative DBS analysis that hold their position in court. A consequent HCT strategy for dried blood should be implemented, as the measurement of HCT in dried blood is not as straightforward as in liquid blood. Solutions for HCT measurement from DBS are available and ready to be implemented. The preferred strategy for HCT assessment should be post-sampling and non-destructive, as it keeps the DBS sampling process as simple as possible. Depending on the DBS sampling device in action, the indirect HCT assessment from the dried matrix can be easier or more difficult to implement. Strategies to rapidly measure the HCT from DBS cards non-destructively have been demonstrated in the past. Up to date, no such application has been introduced for the non-card-based microsampling devices.

https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.2977

mentioned products

The following products were used in this case study

Continue reading

Automated high-throughput analysis of tramadol and O-desmethyltramadol in dried blood spots

Abstract

The World Anti-Doping Agency (WADA) and the International Testing Agency (ITA) recently announced the development and implementation of dried blood spot (DBS) testing for routine analysis in time for the 2022 Winter Olympic and Paralympic Games in Beijing. Following the introduction of a ban on the use of tramadol in competition in March 2019, the Union Cycliste International (UCI) started a pilot study for the manual analysis of tramadol in DBS for antidoping purposes. In this context, we present a fully automated LC–MS/MS-based method with automated sample preparation using a CAMAG DBS-MS 500 for the analysis of tramadol and its metabolite O-desmethyltramadol in DBS. The presented approach reduces manual handling in the laboratory to an absolute minimum, only requiring the preparation of calibration and quality control DBS cards. The method was developed, optimized, and validated before performing cross-validation with a liquid blood-based analysis method using authentic samples from forensic cases. During the validation process, the method showed an extraction efficiency of 62%, linearity r2 > 0.99, accuracy and precision (within ± 15% and ± 20% at the LLOQ) for the determination of tramadol and O-desmethyltramadol. Method comparison in liquid blood with 26 samples showed good agreement (90 ± 19% for tramadol and 94 ± 14% for O-desmethyltramadol). In conclusion, automated analysis of tramadol and O-desmethyltramadol in DBS provides a fast and accurate solution for antidoping screening. It is suited for highthroughput analysis, having a run time of about 4 min per sample. Furthermore, with the automated approach, manual sample extraction becomes obsolete.

https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.2819

mentioned products

The following products were used in this case study

Continue reading